首页> 外国专利> New aryl heteroaromatic compounds useful as tubulin polymerization inhibitors and tumor cell proliferation inhibitors

New aryl heteroaromatic compounds useful as tubulin polymerization inhibitors and tumor cell proliferation inhibitors

机译:新的芳基杂芳族化合物可用作微管蛋白聚合抑制剂和肿瘤细胞增殖抑制剂

摘要

Aryl heteroaromatic compounds (I) are new. Aryl heteroaromatic compounds of formula (I) and their isomers, prodrugs and salts are new. [Image] A : N or C; L1-G1-R1a piperazine residue of formula (i) or a 1,2,5,6-tetrahydropyridine residue of formula (ii); X, Y1CR3, N, NR3, O or S; E1CR4, N, NR4 or S; R1, R2optionally substituted aryl or heteroaryl; L1CO, CS or C=NR7; R3, R4H, alkyl, cycloalkyl, cycloalkenyl, heterocyclyl, OR7, SR7, SOR7, SO2R7, NR7R8, halo, aryl, heteroaryl, substituted cycloalkyl, substituted aryl or substituted heteroaryl; R5, R6H or 1-3C alkyl; and R7, R8H or optionally substituted 1-3C alkyl. Provided that (I) are not 1-phenyl-4-R2-3-(4-R1-1-piperazinecarbonyl)-1H-pyrazoles in which R1/R2 is 2-chlorophenyl/2-thienyl, 2-methoxyphenyl/2-thienyl, 2-methoxyphenyl/3,4-dimethoxyphenyl, 2-methoxyphenyl/3-pyridyl, 3-trifluoromethylphenyl/4-methoxyphenyl, 2-methoxyphenyl/4-chlorophenyl, phenyl/2-thienyl, phenyl/phenyl, 2-methoxyphenyl/4-fluorophenyl or phenyl/4-chlorophenyl, and (I) are not 1-(3-mesyl-2-naphthyl)-3-methyl-5-(4-(4-pyridyl)-1-piperazinecarbonyl)-1H-pyrazole, 1-phenyl-5-(4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinecarbonyl)-1H-pyrazole, 3-(4-fluorophenyl)-4-(4-phenyl-1-piperazinecarbonyl)-isoxazole or 3-phenyl-4-(4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinecarbonyl)-1,2,5-oxadiazole or its N-oxide or N,N-dioxide. [Image] ACTIVITY : Cytostatic; Antiarteriosclerotic. MECHANISM OF ACTION : Tubulin polymerization inhibitor; Tumor cell proliferation inhibitor. (4-(3-Chlorophenyl)-1-piperazinyl)-(1-phenyl-1H-imidazol-2-yl)-methanone had an IC50 of 2 mu M against tubulin polymerization and 0.0296 mu M against HCT116 cell proliferation.
机译:芳基杂芳族化合物(I)是新的。式(I)的芳基杂芳族化合物及其异构体,前药和盐是新的。 [图片] A:N或C; L1> -G1> -R1>式(i)的哌嗪残基或式(ii)的1,2,5,6-四氢吡啶残基; X,Y1> CR3>,N,NR3>,O或S; E1> CR4>,N,NR4>或S; R1>,R2>任选取代的芳基或杂芳基; L1> CO,CS或C = NR7>; R3>,R4> H,烷基,环烷基,环烯基,杂环基,OR7>,SR7>,SOR7>,SO2R7>,NR7> R8>,卤素,芳基,杂芳基,取代的环烷基,取代的芳基或取代的杂芳基; R5>,R6> H或1-3C烷基; R7>,R8> H或任选取代的1-3C烷基。 (I)不是其中R1 / R2是2-氯苯基/ 2-噻吩基,2-甲氧基苯基/ 2-的1-苯基-4-R2-3-(4-R1-1-哌嗪羰基)-1H-吡唑噻吩基,2-甲氧基苯基/ 3,4-二甲氧基苯基,2-甲氧基苯基/ 3-吡啶基,3-三氟甲基苯基/ 4-甲氧基苯基,2-甲氧基苯基/ 4-氯苯基,苯基/ 2-噻吩基,苯基/苯基,2-甲氧基苯基/ 4-氟苯基或苯基/ 4-氯苯基和(I)不是1-(3-甲磺酰基-2-萘基)-3-甲基-5-(4-(4-吡啶基)-1-哌嗪羰基)-1H-吡唑,1-苯基-5-(4-(4-(6-氨基-6,7-二甲氧基-2-喹唑啉基)-1-哌嗪羰基)-1H-吡唑,3-(4-氟苯基)-4-(4-苯基-1-哌嗪羰基)-异唑或3-苯基-4-(4-(4-氨基-6,7-二甲氧基-2-喹唑啉基)-1-哌嗪羰基)-1,2,5-恶二唑或其N-氧化物或N,N-二氧化物。 [图像]活动:细胞抑制作用;抗动脉硬化。作用机理:微管蛋白聚合抑制剂;肿瘤细胞增殖抑制剂。 (4-(3-氯苯基)-1-哌嗪基)-(1-苯基-1H-咪唑-2-基)-甲酮对微管蛋白聚合的IC50为2μM,对HCT116细胞增殖的IC50为0.0296μM。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号